Published in
American Society of Hematology, Blood, 11(123), p. 1699-1708, 2014
DOI: 10.1182/blood-2013-07-509885
Links
- ORCID
- American Society of Hematology | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes
Journal article published in 2014 by
Nyasha Chambwe 
,
Matthias Kormaksson,
Huimin Geng,
Subhajyoti De,
Franziska Michor,
Nathalie A. Johnson,
Ryan D. Morin,
David W. Scott,
Lucy A. Godley,
Randy D. Gascoyne,
Ari Melnick,
Fabien Campagne,
Rita Shaknovich
,
Matthias Kormaksson,
Huimin Geng,
Subhajyoti De,
Franziska Michor,
Nathalie A. Johnson,
Ryan D. Morin,
David W. Scott,
Lucy A. Godley,
Randy D. Gascoyne,
Ari Melnick,
Fabien Campagne,
Rita Shaknovich
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Unsupervised clustering of DLBCLs based on DNA methylation changes identifies 6 novel epigenetic clusters. Greater magnitude of methylation changes correlates with worse clinical outcome.